Skip to content
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
×
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
/
Specialty
/
Allergy and Immunology
/ Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma
Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma
Complimentary
Categories:
Activity Type
,
Allergy and Immunology
,
ANCC
,
CME
,
Credit Type
,
Family Medicine
,
Internal Medicine
,
Nurse
,
Nurse Practitioner
,
Online Activity
,
Physician
,
Physician Assistant
,
Profession
,
Pulmonology
Related products
Sustained-Release Drug Delivery System in the Management of Glaucoma
Read more
Emerging Strategies in the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
Read more
Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Read more
Emerging Treatment Options for Pustular Psoriasis
Read more
Scroll To Top